Tag Archives: Bapineuzumab

Bapineuzumab: Alzheimer’s Drug Trials Halted (Healthcare Today UK)

Summary Two U.S. drug companies have halted trials of bapineuzumab, an experimental drug to treat Alzheimer’s Disease. The drug failed to produce any improvement in the symptoms of dementia sufferers. Pfizer Inc. and Johnson & Johnson had been testing bapineuzumab, which had been designed … Continue reading

Posted in For Doctors (mostly), For Researchers (mostly), In the News, International, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged , , , , , , , , , , | Leave a comment